Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Alzheimer disease”

Brain Wave Informed Non-invasive Brain Stimulation: Improving Neural Networks of Working Memory in Dementia: a Proof-of-concept StudyRecruiting
NCT07673770NAUpdated Jul 7, 2026
Sponsor: McMaster University
Dementia · Alzheimer s Disease
Canada
Epidemiology and Biomarker Study in Alzheimer's DiseaseRecruiting
NCT07142954Phase 3Updated Jul 7, 2026
Sponsor: Eli Lilly and Company
Alzheimer Disease
United States, Japan
Evaluation System for Lecanemab Efficacy Using Gold Electrode ECL to Monitor Alzheimer's BiomarkersRecruiting
NCT07688460Phase 4Updated Jul 7, 2026
Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Alzheimer Disease
China
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)Recruiting
NCT05980949Phase 3Updated Jul 6, 2026
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Psychosis Associated With Alzheimer's Disease
United States, Argentina, Belgium, Brazil, Bulgaria +26 more
Time-in-bed Restriction in Older Adults With Sleep Difficulties With and Without Risk for Alzheimer's DiseaseCompleted
NCT05138848EARLY_Phase 1Updated Jul 6, 2026
Sponsor: University of Pittsburgh
Alzheimer Disease, Late Onset · Mild Cognitive Impairment · Sleep · Cognitive Change
United States
The Brain Health Study: A Pragmatic, Patient-Centered TrialCompleted
NCT05356702NAUpdated Jul 6, 2026
Sponsor: Kaiser Permanente
Dementia · Alzheimer Disease
United States
The Care for America's Aging StudyNot Yet Recruiting
NCT06021704NAUpdated Jul 6, 2026
Sponsor: Massachusetts General Hospital
Cognitive Impairment · Dementia With Behavioral Disturbance · Dementia · Alzheimer Disease
United States
Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's DiseaseRecruiting
NCT04576793Phase 2Updated Jul 6, 2026
Sponsor: Columbia University
Alzheimer Disease
United States
The Gut - PRO StudyNot Yet Recruiting
NCT07413744Phase 2Updated Jul 2, 2026
Sponsor: University of Wisconsin, Madison
Alzheimer Disease
United States
Clinical Study of SNK01 in Participants With Moderate Alzheimer's DiseaseRecruiting
NCT06189963Phase 1, Phase 2Updated Jul 2, 2026
Sponsor: NKGen Biotech, Inc.
Moderate Alzheimer Disease
United States, Canada
Financial Counseling for Dementia Family Caregivers in Early and Middle AdulthoodRecruiting
NCT07681401NAUpdated Jul 2, 2026
Sponsor: University of Utah
Family Caregivers · Dementia · Financial Wellbeing · Financial Coaching
United States
Autophagy-Enhancers to Reduce Sleep DisturbancesRecruiting
NCT07383311NAUpdated Jul 2, 2026
Sponsor: University Medicine Greifswald
Mild Cognitive Impairment Due to Alzheimer's Disease · Subjective Cognitive Decline (SCD)
Germany
Stimulation to Improve MemoryCompleted
NCT03875326NAUpdated Jul 2, 2026
Sponsor: University of Michigan
Mild Cognitive Impairment · Dementia of Alzheimer Type
United States
The BRidge Towards Implementation of Blood-based Biomarkers to Enable Early and Accurate Diagnosis of Alzheimer's DiseaseRecruiting
NCT07680335NAUpdated Jul 2, 2026
Sponsor: Alzheimercentrum Amsterdam
Alzheimer Blood Biomarkers · Alzheimer's Disease (AD)
Netherlands
A Scalable Nutrition Adherence InterventionCompleted
NCT06121986NAUpdated Jul 1, 2026
Sponsor: Florida State University
Alzheimer Disease · Mild Cognitive Impairment · Adherence
United States
ALZEVIT: Nationwide Digital APOE ε4 Cohort for Early Alzheimer's Disease Prevention and Trial ReadinessRecruiting
NCT07679906N/AUpdated Jul 1, 2026
Sponsor: Firalis SA
Alzheimer
France
Sirtuin-NAD Activator in Alzheimer's DiseaseCompleted
NCT05040321Phase 1, Phase 2Updated Jul 1, 2026
Sponsor: Brigham and Women's Hospital
Alzheimer's Disease (Incl Subtypes) · Dementia
United States
GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial EmulationCompleted
NCT07677865N/AUpdated Jul 1, 2026
Sponsor: West China Hospital
Alzheimer Disease · Diabetes Mellitus Type 2 · Obesity & Overweight
China
A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)Terminated
NCT06721156Phase 2Updated Jul 1, 2026
Sponsor: Merck Sharp & Dohme LLC
Alzheimer Disease · Dementia
United States, Argentina, Canada, Italy, Japan +4 more
Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) StudyNot Yet Recruiting
NCT05809908Phase 3Updated Jul 1, 2026
Sponsor: Cerecin
Alzheimer Disease
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's DiseaseRecruiting
NCT07328451Phase 1Updated Jul 1, 2026
Sponsor: Denali Therapeutics Inc.
Alzheimer Disease, Early Onset
Netherlands, United Kingdom
Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's DementiaCompleted
NCT04430517EARLY_Phase 1Updated Jun 30, 2026
Sponsor: Mclean Hospital
Mild Cognitive Impairment · Mild Alzheimer Disease
United States
Fasting ENHANCE Pilot StudyCompleted
NCT05732935NAUpdated Jun 30, 2026
Sponsor: University of Florida
Overweight and Obesity · Time Restricted Feeding · Alzheimer Disease
United States
Clinical Risk Score Prediction for Risk of Dementia Among Late-life Population With DepressionRecruiting
NCT07676851N/AUpdated Jun 30, 2026
Sponsor: Second Affiliated Hospital of Nanchang University
Alzheimer Dementia (AD) · Dementia · Late Life Depression (LLD) · Risk Scores
China
A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of AgeActive Not Recruiting
NCT05399888Phase 2Updated Jun 30, 2026
Sponsor: Biogen
Mild Cognitive Impairment Due to Alzheimer's Disease · Alzheimer's Disease Dementia
United States, Australia, Belgium, Canada, Czechia +12 more

Previous page Next page